| – | Study population | CVIS clinic | |
|---|---|---|---|
| N | 72 | 1533 | |
| Age, years (median [IQR]) | 51 [43, 57] | 52 [44, 59] | |
| Sex (%) | Female | 12 (16.7%) | 486 (31.7%) |
| Male | 60 (83.3%) | 1047 (68.3%) | |
| Infection Type (%) | HIV mono-infected | 43 (59.7%) | 1363 (88.9%) |
| HIV/HCV co-infected | 29 (40.3%) | 170 (11.1%) | |
| HIV transmission risk-factors (%) | MSM | 29 (40.3%) | 470 (30.7%) |
| PWID | 28 (38.9%) | 104 (6.8%) | |
| Endemic country | 8 (11.1%) | 347 (22.6%) | |
| Heterosexual/Other | 12 (16.7%) | 419 (27.3%) | |
| Lowest recorded CD4* (median [IQR]) | 533 [341.5, 702.5] | 529 [355, 728] | |
| Highest recorded VL* (median [IQR]) | <40 [<40, <40] | <40 [<40, <40] | |
| Detectable VL* (%) | 17 (23.6%) | 245 (16.0%) | |